Axcella Receives Fourth Patent Covering EMM Compositions

Axcella Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Axcella Announces Oral Presentation at 2020 International Conference on Frailty and Sarcopenia Research

Axcella Completes Enrollment of Subjects in AXA1665-002 Study

Axcella to Present at the SVB Leerink 9th Annual Global Healthcare Conference

Axcella to Present at J.P. Morgan Healthcare Conference

Axcella Announces Positive Interim Findings from Ongoing Clinical Study of AXA1125/AXA1957 in Subjects with NAFLD and Expected 2020 Milestones